Apolipoprotein E (APOE), which is believed to be associated with AD pathogenesis, has been reported to modulate the response to DNP treatment; ABCA1, which plays a key role in cholesterol transport and APOE metabolism in the brain, has been reported to be related to Alzheimer's disease. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.